Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PTA plus ramipril versus PTA plus placebo for intermittent claudication
2012-005449-19Phase 4Terminated
- Sponsor
- Hull University Teaching Hospitals
- Start
- Mar 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of ramipril in arteriosclerosis obliterans, intermittent claudication (IC), sponsored by Hull University Teaching Hospitals. Started Mar 2013; status: terminated.
02
Drugs
ramipril
03
Conditions
arteriosclerosis obliteransintermittent claudication (IC)
Beyond the preview
Go deeper on 2012-005449-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2012-005449-19.